Abstract:RNA methylation modifications have been found for decades of years, which occur at different RNA types of numerous species, and their distribution is species-specific. However, people rarely know their biological functions. There are several identified methylation modifications in eukaryotic messenger RNA (mRNA), such as N7-methylguanosine (m7G) at the cap, N6-methyl-2′-O-methyladenosine (m6Am), 2′-O-methylation (Nm) within the cap and the internal positions, and internal N6-methyladenosine (m6A) and 5-methylcytosine (m5C). Among them, m7G cap was studied more clearly and found to have vital roles in several important mRNA processes like mRNA translation, stability and nuclear export. m6A as the most abundant modification in mRNA was found in the 1970s and has been proposed to function in mRNA splicing, translation, stability, transport and so on. m6A has been discovered as the first RNA reversible modification which is demethylated directly by human fat mass and obesity associated protein (FTO) and its homolog protein, alkylation repair homolog 5 (ALKBH5). FTO has a special demethylation mechanism that demethylases m6A to A through two over-oxidative intermediate states: N6-hydroxymethyladenosine (hm6A) and N6-formyladenosine (f6A). The two newly discovered m6A demethylases, FTO and ALKBH5, significantly control energy homeostasis and spermatogenesis, respectively, indicating that the dynamic and reversible m6A, analogous to DNA and histone modifications, plays broad roles in biological kingdoms and brings us an emerging field “RNA Epigenetics”. 5-methylcytosine (5mC) as an epigenetic mark in DNA has been studied widely, but m5C in mRNA is seldom explored. The bisulfide sequencing showed m5C is another abundant modification in mRNA, suggesting that it might be another RNA epigenetic mark. This review focuses on the main methylation modifications in mRNA to describe their formation, distribution, function and demethylation from the current knowledge and to provide future perspectives on functional studies.

PCIF1 Catalyzes m6Am mRNA Methylation to Regulate Gene Expression

PCIF1, the only methyltransferase of N6,2-O-dimethyladenosine

Identification of the m6Am Methyltransferase PCIF1 Reveals the Location and Functions of m6Am in the Transcriptome

Rna N-6-Methyladenosine Methylation In Post-Transcriptional Gene Expression Regulation

Cap-Specific m6Am Methyltransferase PCIF1/CAPAM Regulates mRNA Stability of RAB23 and CNOT6 through the m6A Methyltransferase Activity

Cap-specific Terminal N6-methyladeonsine Methylation of RNA Mediated by PCIF1 and Possible Therapeutic Implications

The Mammalian Cap-Specific m6Am RNA Methyltransferase PCIF1 Regulates Transcript Levels in Mouse Tissues

The cap-specific m6A methyltransferase, PCIF1/CAPAM, is dynamically recruited to the gene promoter in a transcription-dependent manner

Enzymatic characterization of mRNA cap adenosine-N6 methyltransferase PCIF1 activity on uncapped RNAs

Cap-specific terminal N 6-methylation of RNA by an RNA polymerase II-associated methyltransferase

m6Am methyltransferase PCIF1 negatively regulates ciliation by inhibiting BICD2 expression

Post-transcriptional gene regulation by mRNA modifications

Rna Modification N-6-Methyladenosine in Post-Transcriptional Regulation

The CTBP2-PCIF1 complex regulates m6Am modification of mRNA in head and neck squamous cell carcinoma

Regulation of m6Am RNA modification and its implications in human diseases

m 6 Am methyltransferase PCIF1 is essential for aggressiveness of gastric cancer cells by inhibiting TM9SF1 mRNA translation

M6am Methyltransferase PCIF1 is Essential for Aggressiveness of Gastric Cancer Cells by Inhibiting TM9SF1 Mrna Translation.

Regulation of Gene Expression by m6Am RNA Modification

Enzymatic Characterization of In Vitro Activity of RNA Methyltransferase PCIF1 on DNA

m6Am Methyltransferase PCIF1 Regulates Periodontal Inflammation

Methylation modifications in eukaryotic messenger RNA.